ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag hiv books infectious disease innovation

Human blood in a plastic Intravenous drip bag, the tube running out of the image. Square crop. Horizontal with copy space.
Opinion: What the History of Blood Transfusion Reveals About Risk
Paul A. Offit | Sep 1, 2021 | 5 min read
Every medical intervention—even one with a centuries-long history—brings dangers, some of which become clear only later.
A fruit bat in the hands of a researcher
How an Early Warning Radar Could Prevent Future Pandemics
Amos Zeeberg, Undark | Feb 27, 2023 | 8 min read
Metagenomic sequencing can help detect unknown pathogens, but its widespread use faces challenges.
Inspired by Nature
Daniel Cossins | Aug 1, 2015 | 10+ min read
Researchers are borrowing designs from the natural world to advance biomedicine.
Fighting the 10/90 Gap
Ricki Lewis | May 12, 2002 | 5 min read
While wealthy nations pursue drugs to treat baldness and obesity, depression in dogs, and erectile dysfunction, elsewhere millions are sick or dying from preventable or treatable infectious and parasitic diseases.1 It's called the 10/90 gap. "Less than 10% of the worldwide expenditure on health research and development is devoted to the major health problems of 90% of the population," explains Els Torreele, co-chair of a working group that provided background recently for an initiative announced
Frontlines
Harvey Black | Sep 15, 2002 | 6 min read
Frontlines Image: Anne MacNamara Math is life Mathematicians and biologists now have a few more reasons to pool resources and expertise. New grants cosponsored by the National Science Foundation and the National Institute of General Medical Sciences (NIGMS) are available to scientists who apply innovative mathematical approaches to biological problems (www.nsf.gov/pubs/2002/nsf02125/nsf02125.htm). The two agencies have awarded 20 grantees roughly $24 million over the next five years and wil
AIDS Research Progress Stymied By Narrow Focus, Critics Charge
Franklin Hoke | Jul 10, 1994 | 9 min read
Critics Charge Author: FRANKLIN HOKE, pp.1 Date: July 11,1994 Disputing what they see as unproductive preoccupation with HIV-specific studies, they step up campaign for a `wider window' of research Progress in AIDS research has faltered in the United States since the mid-1980s, according to some scientists, owing to a premature narrowing of the research focus by the scientific and administrative leadership of the National Inst
AIDS Research Progress Stymied By Narrow Focus, Critics Charge
Franklin Hoke | Jul 10, 1994 | 9 min read
Critics Charge Author: FRANKLIN HOKE, pp.1 Date: July 11,1994 Disputing what they see as unproductive preoccupation with HIV-specific studies, they step up campaign for a `wider window' of research Progress in AIDS research has faltered in the United States since the mid-1980s, according to some scientists, owing to a premature narrowing of the research focus by the scientific and administrative leadership of the National Inst
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
A Dime a Dozen
Megan Scudellari | Jan 1, 2013 | 7 min read
Affordable diagnostic tests tackle the world’s most pressing health problems.
D Remains Stagnant Despite Scientific Advances
Myrna Watanabe | Sep 15, 1996 | 10+ min read
SIDEBAR: Mired in Politics: Emergency Contraceptives And Abortifacients LITTLE PROGRESS NOTED: "Why should a pharmaceutical company take these risks?" asks pioneer Carl Djerassi. Although the molecular biology revolution is in full swing and potential new products abound, basic methods of birth control have changed little in the 36 years since the contraceptive pill was introduced. Indeed, some scientists believe that political and economic pressures will keep most contraceptive advances -- e

Run a Search

ADVERTISEMENT